Literature DB >> 16204337

Perinatal testosterone surge is required for normal adult bone size but not for normal bone remodeling.

Natalie A Sims1, Karen Brennan, Jenny Spaliviero, David J Handelsman, Markus J Seibel.   

Abstract

Although testosterone (T) has striking effects on mature skeletal size and structure, it is not clear whether this depends exclusively on adult circulating levels of T or whether additional early-life factors also play a role. We have compared the androgen-deficient hypogonadal (hpg) mutant mouse with intact, orchidectomized, and T-treated non-hpg mice to determine relative contributions of adult and perinatal T to bone growth and development. At 3 wk of age, although trabecular and cortical bone structure was normal, bone turnover was significantly altered in hpg male mice; osteoid volume (OV/BV) and osteoblast surface (ObS/BS) were significantly lower and osteoclast surface (OcS/BS) significantly higher in hpg mice compared with age-matched non-hpg mice, pointing to a role for the perinatal T surge in determining bone turnover levels before sexual maturity. At 9 wk of age, the hpg bone phenotype mimicked closely that of age-matched non-hpg mice that had been orchidectomized at 3 wk of age, including low trabecular bone mass and high bone turnover. These bone phenotypes of hpg and orchidectomized non-hpg mice were all prevented by replacement doses of T or dihydrotestosterone (DHT), suggesting that these are determined by adult sex steroid hormones. In contrast, a short bone phenotype that could not be prevented by T or DHT treatment was observed in 9-wk-old hpg mice yet not in intact or castrated non-hpg mice. These data suggest a role for the perinatal T surge in determining adult bone length and confirms that adult circulating T determines adult bone density.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16204337     DOI: 10.1152/ajpendo.00311.2005

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  25 in total

1.  Germline deletion of AMP-activated protein kinase beta subunits reduces bone mass without altering osteoclast differentiation or function.

Authors:  Julian M W Quinn; Shanna Tam; Natalie A Sims; Hasnawati Saleh; Narelle E McGregor; Ingrid J Poulton; John W Scott; Matthew T Gillespie; Bruce E Kemp; B J W van Denderen
Journal:  FASEB J       Date:  2009-09-01       Impact factor: 5.191

2.  Age-related changes in biochemical markers of bone turnover and gonadotropin levels and their relationship among Chinese adult women.

Authors:  X-Y Wu; X-P Wu; H Xie; H Zhang; Y-Q Peng; L-Q Yuan; X Su; X-H Luo; E-Y Liao
Journal:  Osteoporos Int       Date:  2009-06-27       Impact factor: 4.507

3.  Neonatal estrogen exposure results in biphasic age-dependent effects on the skeletal development of male mice.

Authors:  Kara J Connelly; Emily A Larson; Daniel L Marks; Robert F Klein
Journal:  Endocrinology       Date:  2015-01       Impact factor: 4.736

4.  Lactating Ctcgrp nulls lose twice the normal bone mineral content due to fewer osteoblasts and more osteoclasts, whereas bone mass is fully restored after weaning in association with up-regulation of Wnt signaling and other novel genes.

Authors:  Jillian N Collins; Beth J Kirby; Janine P Woodrow; Robert F Gagel; Clifford J Rosen; Natalie A Sims; Christopher S Kovacs
Journal:  Endocrinology       Date:  2013-03-05       Impact factor: 4.736

5.  Osteoblasts Are Rapidly Ablated by Virus-Induced Systemic Inflammation following Lymphocytic Choriomeningitis Virus or Pneumonia Virus of Mice Infection in Mice.

Authors:  Steven Maltby; Alyssa J Lochrin; Bianca Bartlett; Hock L Tay; Jessica Weaver; Ingrid J Poulton; Maximilian W Plank; Helene F Rosenberg; Natalie A Sims; Paul S Foster
Journal:  J Immunol       Date:  2017-12-06       Impact factor: 5.422

6.  Delayed development of specific thyroid hormone-regulated events in transthyretin null mice.

Authors:  Julie A Monk; Natalie A Sims; Katarzyna M Dziegielewska; Roy E Weiss; Robert G Ramsay; Samantha J Richardson
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-10-23       Impact factor: 4.310

7.  Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice.

Authors:  Emma C Walker; Narelle E McGregor; Ingrid J Poulton; Melissa Solano; Sueli Pompolo; Tania J Fernandes; Matthew J Constable; Geoff C Nicholson; Jian-Guo Zhang; Nicos A Nicola; Matthew T Gillespie; T John Martin; Natalie A Sims
Journal:  J Clin Invest       Date:  2010-01-04       Impact factor: 14.808

8.  Tissue inhibitor of metalloproteinase-3 (TIMP-3) regulates hematopoiesis and bone formation in vivo.

Authors:  Yi Shen; Ingrid G Winkler; Valerie Barbier; Natalie A Sims; Jean Hendy; Jean-Pierre Lévesque
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

9.  Osteoclast inhibitory lectin, an immune cell product that is required for normal bone physiology in vivo.

Authors:  Vicky Kartsogiannis; Natalie A Sims; Julian M W Quinn; Chi Ly; Mirijana Cipetic; Ingrid J Poulton; Emma C Walker; Hasnawati Saleh; Narelle E McGregor; Morgan E Wallace; Mark J Smyth; T John Martin; Hong Zhou; Kong Wah Ng; Matthew T Gillespie
Journal:  J Biol Chem       Date:  2008-09-08       Impact factor: 5.157

10.  Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myeloma.

Authors:  Agatha Labrinidis; Peter Diamond; Sally Martin; Shelley Hay; Vasilios Liapis; Irene Zinonos; Natalie A Sims; Gerald J Atkins; Cristina Vincent; Vladimir Ponomarev; David M Findlay; Andrew C W Zannettino; Andreas Evdokiou
Journal:  Clin Cancer Res       Date:  2009-03-10       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.